Kris Jacobs Vacancies Kris Jacobs Kris Jacobs Loading jobs... Stay updated Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Issue brief Issue brief | 08 November 2022 Tuberculosis DR-TB Drugs Under the Microscope, 8th Edition Prem Hessenkamp Press release Press release | 08 November 2022 Tuberculosis New MSF report warns that major opportunity to increase access to newer, safer DR-TB drugs is at risk 6 min Video Video | 03 November 2022 Tuberculosis MSF commitment to supporting the objectives of the ‘1/4/6 by 24’ campaign 2 min Technical brief | 02 November 2022 Intellectual property and trade Damaging provisions for access to medicines in the UK-India FTA negotiation text Photograph by Atul Loke Press release Press release | 02 November 2022 Intellectual property and trade United KingdomIndia MSF responds to UK's disastrous proposal on intellectual property in UK-India Free Trade Agreement 3 min Photograph by Atul Loke Press release Press release | 27 October 2022 Tuberculosis MSF responds to WHO Global TB Report 2022, calls for scale up of shorter and safer DR-TB treatments to help save more lives 4 min Photograph by Alexandre Marcou Press release Press release | 19 October 2022 Tropical & neglected diseases MSF responds to change in global cholera vaccine strategy amid unprecedented number of outbreaks 3 min Technical brief | 17 October 2022 Research and development Roundtable: How Can Disclosing Clinical Trial Costs Increase Access to Medical Products? Load More
Issue brief Issue brief | 08 November 2022 Tuberculosis DR-TB Drugs Under the Microscope, 8th Edition
Prem Hessenkamp Press release Press release | 08 November 2022 Tuberculosis New MSF report warns that major opportunity to increase access to newer, safer DR-TB drugs is at risk 6 min
Video Video | 03 November 2022 Tuberculosis MSF commitment to supporting the objectives of the ‘1/4/6 by 24’ campaign 2 min
Technical brief | 02 November 2022 Intellectual property and trade Damaging provisions for access to medicines in the UK-India FTA negotiation text
Photograph by Atul Loke Press release Press release | 02 November 2022 Intellectual property and trade United KingdomIndia MSF responds to UK's disastrous proposal on intellectual property in UK-India Free Trade Agreement 3 min
Photograph by Atul Loke Press release Press release | 27 October 2022 Tuberculosis MSF responds to WHO Global TB Report 2022, calls for scale up of shorter and safer DR-TB treatments to help save more lives 4 min
Photograph by Alexandre Marcou Press release Press release | 19 October 2022 Tropical & neglected diseases MSF responds to change in global cholera vaccine strategy amid unprecedented number of outbreaks 3 min
Technical brief | 17 October 2022 Research and development Roundtable: How Can Disclosing Clinical Trial Costs Increase Access to Medical Products?
